Thaler S - Search Results

1

Membrane-anchored peptide inhibits human immunodeficiency virus entry.

Hildinger M, Dittmar MT, Schult-Dietrich P, Fehse B, Schnierle BS, Thaler S, Stiegler G, Welker R, von Laer D. Hildinger M, et al. Among authors: thaler s. J Virol. 2001 Mar;75(6):3038-42. doi: 10.1128/JVI.75.6.3038-3042.2001. J Virol. 2001. PMID: 11222732 Free PMC article.

2

Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.

Höhne M, Thaler S, Dudda JC, Groner B, Schnierle BS. Höhne M, et al. Among authors: thaler s. Virology. 1999 Aug 15;261(1):70-8. doi: 10.1006/viro.1999.9847. Virology. 1999. PMID: 10441556 Free article.

3

A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes.

Thaler S, Schnierle BS. Thaler S, et al. Mol Ther. 2001 Sep;4(3):273-9. doi: 10.1006/mthe.2001.0445. Mol Ther. 2001. PMID: 11545619 Free article.

4

MLV/HIV-pseudotyped vectors: a new treatment option for cutaneous T cell lymphomas.

Thaler S, Burger AM, Schulz T, Schnierle BS. Thaler S, et al. Mol Ther. 2003 Nov;8(5):756-61. doi: 10.1016/s1525-0016(03)00241-7. Mol Ther. 2003. PMID: 14599808 Free article.

5

Assessment of HIV-1 entry inhibitors by MLV/HIV-1 pseudotyped vectors.

Siegert S, Thaler S, Wagner R, Schnierle BS. Siegert S, et al. Among authors: thaler s. AIDS Res Ther. 2005 Sep 12;2:7. doi: 10.1186/1742-6405-2-7. AIDS Res Ther. 2005. PMID: 16156891 Free PMC article.

6

Establishment of a mouse xenograft model for mycosis fungoides.

Thaler S, Burger AM, Schulz T, Brill B, Bittner A, Oberholzer PA, Dummer R, Schnierle BS. Thaler S, et al. Exp Dermatol. 2004 Jul;13(7):406-12. doi: 10.1111/j.0906-6705.2004.00201.x. Exp Dermatol. 2004. PMID: 15217360

7

Targeting AKT signaling sensitizes cancer to cellular immunotherapy.

Hähnel PS, Thaler S, Antunes E, Huber C, Theobald M, Schuler M. Hähnel PS, et al. Among authors: thaler s. Cancer Res. 2008 May 15;68(10):3899-906. doi: 10.1158/0008-5472.CAN-07-6286. Cancer Res. 2008. PMID: 18483275

8

RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt.

Thaler S, Hähnel PS, Schad A, Dammann R, Schuler M. Thaler S, et al. Cancer Res. 2009 Mar 1;69(5):1748-57. doi: 10.1158/0008-5472.CAN-08-1377. Epub 2009 Feb 17. Cancer Res. 2009. PMID: 19223555

9

An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression.

Marques CA, Hähnel PS, Wölfel C, Thaler S, Huber C, Theobald M, Schuler M. Marques CA, et al. Among authors: thaler s. Blood. 2008 Feb 1;111(3):1413-9. doi: 10.1182/blood-2007-05-089458. Epub 2007 Oct 30. Blood. 2008. PMID: 17971488 Free article.

10

Inhibitors of apoptosis confer resistance to tumour suppression by adoptively transplanted cytotoxic T-lymphocytes in vitro and in vivo.

Huber C, Bobek N, Kuball J, Thaler S, Hoffarth S, Huber C, Theobald M, Schuler M. Huber C, et al. Among authors: thaler s. Cell Death Differ. 2005 Apr;12(4):317-25. doi: 10.1038/sj.cdd.4401563. Cell Death Differ. 2005. PMID: 15678149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters